Endocrinology Associates, Inc

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Cushing's syndrome1 trial
• Obesity1 trial
• Type 2 diabetes1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Amgen1 trial
• Sparrow Pharmaceuticals1 trial

Running trials

• Recruiting

  Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  NCT07296484· Phase 2· Sparrow Pharmaceuticals· Source

  Contact: Edward Clinical Research Manager

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Amgen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Cushing's syndrome1 recruiting
• Type 2 diabetes1 recruiting